Infection with a common virus may increase the risk of Type 2 diabetes in older adults, a new study from the Netherlands suggests. In the study, adults ages 85 and over who were infected with ...

CMV is the most common infectious cause of birth defects in the U.S.; there is no approved vaccine to prevent CMV CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Moderna, Inc., (Nasdaq: MRNA) a clinical stage ...

In two phase III trials, the adjuvanted chikungunya virus vaccine achieved its primary and key secondary endpoints in healthy participants 12 years of age and older, reported Jason Richardson, PhD, ...

Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing ...

A shot analysts projected as a multibillion-dollar seller produced results “well below” the company’s expectations, ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of ...

Kamada begins patient enrolment in an investigator-initiated clinical trial of Cytogam to prevent cytomegalovirus in kidney transplantation: Rehovot, Israel Thursday, November 6, ...

The novel coronavirus is not only known for causing mild to severe infections, but is also efficient in leaving a post COVID effect. As per reports, five cases of Cytomegalovirus (CMV), leading to ...

Phase 2 study to confirm dose to be initiated in near term, with planned interim analysis through 3 months; Phase 3 study planning is underway CMV is the most common infectious cause of birth defects ...